Testing effectiveness (Phase 2)Study completedNCT00035243What this trial is testingEPO906 Therapy in Patients With Advanced Kidney CancerWho this might be right forKidney Neoplasms Novartis Pharmaceuticals 53
Large-scale testing (Phase 3)Active Not RecruitingNCT03793166What this trial is testingImmunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE StudyWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more National Cancer Institute (NCI) 1,175
Early research (Phase 1)Ended earlyNCT03483883What this trial is testingAvelumab/Gemcitabine in Sarcomatoid RCCWho this might be right forMetastatic sRCC Abramson Cancer Center at Penn Medicine 6
Early research (Phase 1)Active Not RecruitingNCT05122546What this trial is testingCBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT03685448What this trial is testingANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)Who this might be right forRenal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Early research (Phase 1)Looking for participantsNCT07128680What this trial is testingImmunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01164228What this trial is testingSunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer ECOG-ACRIN Cancer Research Group 87
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692What this trial is testingRP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more City of Hope Medical Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05808608What this trial is testingAK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaFirst-line TreatmentNon Clear Cell Renal Cell Carcinoma+1 more Hao Zeng 37
Testing effectiveness (Phase 2)Looking for participantsNCT06866262What this trial is testingInulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON TrialWho this might be right forLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more University of Michigan Rogel Cancer Center 55
Early research (Phase 1)Looking for participantsNCT06399419What this trial is testingCBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more Osel, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00126503What this trial is testingSorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney CancerWho this might be right forChromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Study completedNCT01664182What this trial is testingTrebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney CancerWho this might be right forAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400